Sandoz, a Novartis division and the pioneer and global leader in biosimilars, announces new data on its proposed biosimilar adalimumab. Data from a long-term study of patients continuously treated with the proposed biosimilar or the reference medicine show that efficacy and safety profiles of the two medicines match throughout 51 weeks of treatment in patients […]

Pfizer and Astellas Pharma announced that the phase 3 PROSPER trial evaluating Xtandi (enzalutamide) plus androgen deprivation therapy (ADT) versus ADT alone in patients with non-metastatic (M0) Castration-Resistant Prostate Cancer (CRPC) met its primary endpoint of improved metastasis-free survival (MFS). Preliminary safety analysis of the PROSPER trial appears consistent with the safety profile of Xtandi […]

Biocon is betting big on small molecules and generic formulations, biosimilars, branded formulations and research services as it targets $1 billion revenue by the next fiscal. Bengaluru-based firm, which has been chasing the target since 2011, has identified these verticals as its key focus areas. Biocon had posted a revenue of Rs 4,078.7 crore in […]

Aurigene Discovery Technologies Ltd, a wholly owned subsidiary of Dr. Reddy’s Laboratories  and Curis, Inc. have announced plans to initiate a Phase 2 trial of CA-170, a PDL1-VISTA inhibitor to be conducted at sites in India. This was announced following the presentation of preliminary data from the initial 34 patients with cancer treated in the […]

Janssen Sciences, the research arm of pharmaceutical giant Johnson & Johnson, will discontinue development of its hepatitis C drug “in light of the increasing availability of a number of highly effective therapies” addressing this medical need. Instead, the company will focus on a cure for chronic hepatitis B, an inflammation of the liver caused by […]

Ce-Chem Pharmaceuticals is planning to set up a bulk drugs unit at Dobaspet industrial area in Bengaluru rural district of Karnataka. Project is estimated to cost Rs 20 crore and will spread over two acre of land.Company is awaiting land allotment from the state government. The consultant, contractor, and machinery supplier yet to be finalised. […]

Global pharmaceutical major Teva’s arm Watson Pharma had rented 105,000 sq ft of office space in L&T Realty’s office complex in Navi Mumbai, said sources in the know. Watson Pharma would pay over Rs 12 crore annual rent, or Rs 95 per sq ft per month on built-up area or Rs 140 on carpet area, […]

Drug maker LupinBSE 0.05 % today announced the launch of its Olmesartan Medoxomil tablets, a hypertension drug, in the US market. Company has launched the tablets in strengths of 5 mg, 20 mg and 40 mg after having received an approval from the United States Food and Drug Administration () earlier, Lupin LtdBSE 0.05 % […]

MoU was signed by Parveen Garg, Chairman, ISFCP and Prof. Raghuram Rao, Director, NIPER, Mohali) in the presence of Dr. Savina Bansal, Dean (R & D), Dr. R. K. Bansal, Dean, (Student welfare), MRSPTU, Bathinda, Dr. P. V. Bharatam, Dean, NIPER, (Guest of Honour), Er. Janesh Garg, Secretary ISFCP and Prof. G.D. Gupta, Director, ISFCP […]

Dr.Reddy’s Laboratories Ltd,, through its wholly owned subsidiary Promius Pharma, has out-licensed the future development, manufacturing, and commercialisation rights of DFD-06, a topical high-potency steroid, to Encore Dermatology. Drug is intended to be used for treatment of moderate to severe plaque psoriasis.Under the terms of the agreement, Encore will be responsible for the commercialisation of […]